Results Champions Oncology Inc.
-
Quarterly Report for Quarter Ending July 31, 2025 (Form 10-Q)
-2d
-
Radiopharmaceutical Efficacy Studies in PDX Models: Why Tumor Diversity Matters
9/9
-
Radiochemistry 101 for ADC Teams: A Practical Guide to Smarter Biodistribution Studies
8/28
-
FDA Guidance: The Future of Radiopharmaceutical Development
8/26
-
Additional Proxy Soliciting Materials (Form DEFA14A)
8/22
-
Proxy Statement (Form DEF 14A)
8/22
-
Radiopharmaceuticals in Cancer Treatment: Insights from Mike Ritchie
8/21
-
Seeing Beyond Efficacy: How Radiolabeling Advances ADC Drug Development
8/15
-
Annual Report for Fiscal Year Ending April 30, 2025 (Form 10-K)
7/23
-
Beyond TCGA: TumorGraft’s New Frontier in Cancer Research
7/15